Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of X-Linked Agammaglobulinaemia Patients.

Journal of clinical immunology - 14 Nov 2024

Shillitoe Ben, Duque Jaime S Rosa, Lai Sophie H Y, Lau Tsun Ming, Chan Jeffery C H, Bourne Helen, Stroud Catherine, Flood Terry, Buckland Matthew, Ip Winnie, Worth Austen, Hackett Scott, Herwadkar Archana, Coulter Tanya, Blaney Catherine, Jolles Stephen, Garcez Tomaz, Moya Eduardo, Faust Saul, Pearce Mark S, Lau Yu Lung, Gennery Andrew R

Abstract excerpt

BACKGROUND: X-linked agammaglobulinaemia (XLA), caused by mutations in BTK, is characterised by low or absent peripheral CD19 + B lymphocytes and agammaglobulinaemia. The mainstay of treatment consists of immunoglobulin replacement therapy (IgRT). As this cannot fully compensate for the immune defects in XLA, patients may therefore continue to be at risk of complications. OBJECTIVES: To describe the clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Agammaglobulinaemia Tyrosine Kinase
Share to Agammaglobulinemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bronchiectasis

Share to Genetic Diseases, X-Linked

Share to Hong Kong

Share to Immunoglobulin G

Share to Immunoglobulins, Intravenous

Share to United Kingdom

Source

Identifiers

PMID: 39541002
DOI: 10.1007/s10875-024-01829-z

Genes

BTK
CD19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of X-Linked Agammaglobulinaemia Patients.PMID 39541002Read ↗

Clinical and genetic findings in two siblings with X-Linked agammaglobulinemia and bronchiolitis obliterans: a case report.Semantic proximity Read ↗

Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.Semantic proximity Read ↗

X-linked agammaglobulinemia: Twenty years of single-center experience from North West India.Semantic proximity Read ↗

Clinical features and mutational analysis of X-linked agammaglobulinemia patients in MalaysiaSemantic proximity Read ↗

A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.Semantic proximity Read ↗

Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia.Semantic proximity Read ↗

Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India.Semantic proximity Read ↗

X-Linked Agammaglobulinemia A Clinical and Molecular AnalysisSemantic proximity Read ↗

X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry.Semantic proximity Read ↗

Agammaglobulinemia: from X-linked to Autosomal Forms of Disease.Semantic proximity Read ↗

Clinical and genetic profiles of patients with X-linked agammaglobulinemia from southeast Turkey: Novel mutations in BTK gene.Semantic proximity Read ↗

Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: Report from Shanghai, China (2000-2015).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.